Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s traded shares stood at 2.49 million during the last session, with the company’s beta value hitting 1.12. At the close of
In the latest trading session, 1.96 million Cns Pharmaceuticals Inc (NASDAQ:CNSP) shares changed hands as the company’s beta touched 1.12. With the company’s most recent
In last trading session, Cns Pharmaceuticals Inc (NASDAQ:CNSP) saw 0.67 million shares changing hands with its beta currently measuring 1.06. Company’s recent per share price
Cns Pharmaceuticals Inc (NASDAQ:CNSP) has a beta value of 1.06 and has seen 63.79 million shares traded in the last trading session. The CNSP stock
Cns Pharmaceuticals Inc (NASDAQ:CNSP) has a beta value of 1.06 and has seen 484.66 million shares traded in the last trading session. The company, currently
During the last session, Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s traded shares were 16.64 million, with the beta value of the company hitting 1.04. At the end
During the last session, Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s traded shares were 12.71 million, with the beta value of the company hitting 1.04. At the end
In the last trading session, 4.6 million shares of the Cns Pharmaceuticals Inc (NASDAQ:CNSP) were traded, and its beta was 1.06. Most recently the company’s
Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s traded shares stood at 3.89 million during the last session, with the company’s beta value hitting 1.05. At the close of
Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s traded shares stood at 5.24 million during the last session, with the company’s beta value hitting 1.05. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
